Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Prostate Cancer

Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients
A Phase I, Open-label, Randomized, Parallel, Relative Bioavailability Study Comparing a Capsule and a Tablet Formulation of Enzalutamide Following Multiple Once Daily Doses of 160 mg Enzalutamide in Male Subjects With Prostate Cancer
Status: Enrolling
Updated:  7/15/2013
University of Chicago Medical Center
mi
from
Chicago, IL
Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients
A Phase I, Open-label, Randomized, Parallel, Relative Bioavailability Study Comparing a Capsule and a Tablet Formulation of Enzalutamide Following Multiple Once Daily Doses of 160 mg Enzalutamide in Male Subjects With Prostate Cancer
Status: Enrolling
Updated: 7/15/2013
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients
A Phase I, Open-label, Randomized, Parallel, Relative Bioavailability Study Comparing a Capsule and a Tablet Formulation of Enzalutamide Following Multiple Once Daily Doses of 160 mg Enzalutamide in Male Subjects With Prostate Cancer
Status: Enrolling
Updated:  7/15/2013
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients
A Phase I, Open-label, Randomized, Parallel, Relative Bioavailability Study Comparing a Capsule and a Tablet Formulation of Enzalutamide Following Multiple Once Daily Doses of 160 mg Enzalutamide in Male Subjects With Prostate Cancer
Status: Enrolling
Updated: 7/15/2013
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients
A Phase I, Open-label, Randomized, Parallel, Relative Bioavailability Study Comparing a Capsule and a Tablet Formulation of Enzalutamide Following Multiple Once Daily Doses of 160 mg Enzalutamide in Male Subjects With Prostate Cancer
Status: Enrolling
Updated:  7/15/2013
South Texas Accelerated Research Therapeutics
mi
from
San Antonio, TX
Relative Bioavailability Study of Enzalutamide in Prostate Cancer Patients
A Phase I, Open-label, Randomized, Parallel, Relative Bioavailability Study Comparing a Capsule and a Tablet Formulation of Enzalutamide Following Multiple Once Daily Doses of 160 mg Enzalutamide in Male Subjects With Prostate Cancer
Status: Enrolling
Updated: 7/15/2013
South Texas Accelerated Research Therapeutics
mi
from
San Antonio, TX
Click here to add this to my saved trials
Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate Cancer
Efficacy and Toxicity of Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate Cancer With Progression After Treatment With Docetaxel
Status: Enrolling
Updated:  7/31/2013
Cleveland Clinic Taussig Cancer Center
mi
from
Cleveland, OH
Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate Cancer
Efficacy and Toxicity of Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate Cancer With Progression After Treatment With Docetaxel
Status: Enrolling
Updated: 7/31/2013
Cleveland Clinic Taussig Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
MR-Guided Laser Ablation of Prostate Bed Recurrences
Technical Success, Safety, and Short-term Efficacy for MR-Guided Laser Ablation of Prostate Bed Recurrences
Status: Enrolling
Updated:  8/30/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
MR-Guided Laser Ablation of Prostate Bed Recurrences
Technical Success, Safety, and Short-term Efficacy for MR-Guided Laser Ablation of Prostate Bed Recurrences
Status: Enrolling
Updated: 8/30/2013
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated:  9/3/2013
John Hopkins Medical Center
mi
from
Baltimore, MD
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated: 9/3/2013
John Hopkins Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated:  9/3/2013
Memorial Sloan-Kettering Cancer Center
mi
from
New York, NY
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated: 9/3/2013
Memorial Sloan-Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated:  9/3/2013
Oregon Health and Science University
mi
from
Portland, OR
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated: 9/3/2013
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Collection of Blood Specimens for Circulating Tumor Cell Analysis
Collection of Blood Specimens for Circulating Tumor Cell Analysis
Status: Enrolling
Updated:  9/21/2013
Commonwealth Hematology-Oncology
mi
from
Lawrence, MA
Collection of Blood Specimens for Circulating Tumor Cell Analysis
Collection of Blood Specimens for Circulating Tumor Cell Analysis
Status: Enrolling
Updated: 9/21/2013
Commonwealth Hematology-Oncology
mi
from
Lawrence, MA
Click here to add this to my saved trials
Real-Time MV/kV Image Guided Radiation Therapy
Real-Time MV/kV Image Guided Radiation Therapy
Status: Enrolling
Updated:  12/12/2013
Stanford University School of Medicine
mi
from
Stanford, CA
Real-Time MV/kV Image Guided Radiation Therapy
Real-Time MV/kV Image Guided Radiation Therapy
Status: Enrolling
Updated: 12/12/2013
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic T2-T3N0 Prostate Cancer
A Phase I/II Trial of Post-Prostatectomy Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic T2-T3NO Prostate Cancer
Status: Enrolling
Updated:  12/30/2013
University of Kansas Medical Center
mi
from
Kansas City, KA
Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic T2-T3N0 Prostate Cancer
A Phase I/II Trial of Post-Prostatectomy Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic T2-T3NO Prostate Cancer
Status: Enrolling
Updated: 12/30/2013
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer
Phase II Study of Carboplatin Plus Docetaxel (Taxotere) in Patients With Anaplastic Prostate Carcinoma
Status: Enrolling
Updated:  1/16/2014
University of California at San Francisco
mi
from
San Francisco, CA
Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer
Phase II Study of Carboplatin Plus Docetaxel (Taxotere) in Patients With Anaplastic Prostate Carcinoma
Status: Enrolling
Updated: 1/16/2014
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer
Phase II Study of Carboplatin Plus Docetaxel (Taxotere) in Patients With Anaplastic Prostate Carcinoma
Status: Enrolling
Updated:  1/16/2014
UT MD Anderson Cancer Center
mi
from
Houston, TX
Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer
Phase II Study of Carboplatin Plus Docetaxel (Taxotere) in Patients With Anaplastic Prostate Carcinoma
Status: Enrolling
Updated: 1/16/2014
UT MD Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Birmingham, AL
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Tucson, AZ
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Burbank, CA
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Burbank, CA
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Encinitas, CA
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Encinitas, CA
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Los Angeles, CA
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
San Diego, CA
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Denver, CO
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
New Haven, CT
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Norwalk, CT
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Norwalk, CT
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Port St. Lucie, FL
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Port St. Lucie, FL
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Honolulu, HI
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Honolulu, HI
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Fairway, KA
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Fairway, KA
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
New Orleans, LA
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Baltimore, MD
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Baltimore, MD
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Rockville, MD
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Rockville, MD
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Boston, MA
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Ann Arbor, MI
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Rochester, MN
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Omaha, NE
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Las Vegas, NV
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Lake Success, NY
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Lake Success, NY
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
New York, NY
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Rochester, NY
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Stony Brook, NY
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Stony Brook, NY
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Huntersville, NC
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Huntersville, NC
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Raleigh, NC
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Cleveland, OH
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Pittsburgh, PA
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Providence, RI
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Providence, RI
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Greenville, SC
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Greenville, SC
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Myrtle Beach, SC
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Memphis, TN
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Dallas, TX
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Norfolk, VA
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated:  2/10/2014
Clinical Research Facility
mi
from
Seattle, WA
A Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Phase 2, Open-label, Multicenter Study of PSMA ADC in Subjects With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling
Updated: 2/10/2014
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer.
A Phase Ib Multicentre Study of AZD5363 Monotherapy to Assess Anti-Tumour Activity,Safety,Tolerability,and Pharmacokinetics in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC)(PYRUS)
Status: Enrolling
Updated:  4/28/2014
Clinical Research Facility
mi
from
Sarasota, FL
Investigating Safety, Tolerability and Efficacy of AZD5363 in Prostate Cancer.
A Phase Ib Multicentre Study of AZD5363 Monotherapy to Assess Anti-Tumour Activity,Safety,Tolerability,and Pharmacokinetics in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC)(PYRUS)
Status: Enrolling
Updated: 4/28/2014
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials